Explore more publications!

Latest News

Labels On
FILTER THE FEED
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
FILTER THE FEED
Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Decoding the 2025 Nobel Prize in Physiology or Medicine: The discovery of regulatory T cells, the “brakes” of immune responses

Decoding the 2025 Nobel Prize in Physiology or Medicine: The discovery of regulatory T cells, the “brakes” of immune responses

Center-left The National Tribune
Owner: The National Tribune Australia
Former Mt. Gox CEO Mark Karpelès Reveals Details of 2014 Collapse and Japanese Detention

Former Mt. Gox CEO Mark Karpelès Reveals Details of 2014 Collapse and Japanese Detention

Neutral Bitcoin Magazine - Tennessee
Owner: David Bailey

Samsung Bioepis Announces Approval of Ustekinumab Biosimilar in Japan

Center-right Financial Post
Owner: Anthony Melchiorre
Japan’s former emperor turns 92 as heart condition stabilizes after health concerns

Japan’s former emperor turns 92 as heart condition stabilizes after health concerns

Japan's Takumi Minamino suffers knee injury, World Cup campaign in doubt

Japan's Takumi Minamino suffers knee injury, World Cup campaign in doubt

Hospitals, defence stocks set for multi-year growth as capex and orders rise: Mayuresh Joshi

Hospitals, defence stocks set for multi-year growth as capex and orders rise: Mayuresh Joshi

Press Release: Sanofi And Regeneron's Dupixent Approved In Japan For Children Aged 6 To 11 Years With Bronchial Asthma

Press Release: Sanofi And Regeneron's Dupixent Approved In Japan For Children Aged 6 To 11 Years With Bronchial Asthma

Blow for Nxera Pharma as Boehringer Ingelheim decides against licensing its schizophrenia compounds

Blow for Nxera Pharma as Boehringer Ingelheim decides against licensing its schizophrenia compounds

Soccer-Japan's Minamino ruptures ACL, World Cup campaign in doubt

Soccer-Japan's Minamino ruptures ACL, World Cup campaign in doubt

Frozen-food experiment brings 24-hour meal options to remote posts across Japan

Frozen-food experiment brings 24-hour meal options to remote posts across Japan

Japan’s former emperor turns 92 as heart condition stabilizes after health concerns

Japan’s former emperor turns 92 as heart condition stabilizes after health concerns

Japan's Takumi Minamino suffers knee injury, World Cup campaign in doubt

Japan's Takumi Minamino suffers knee injury, World Cup campaign in doubt

Hospitals, defence stocks set for multi-year growth as capex and orders rise: Mayuresh Joshi

Hospitals, defence stocks set for multi-year growth as capex and orders rise: Mayuresh Joshi

Press Release: Sanofi And Regeneron's Dupixent Approved In Japan For Children Aged 6 To 11 Years With Bronchial Asthma

Press Release: Sanofi And Regeneron's Dupixent Approved In Japan For Children Aged 6 To 11 Years With Bronchial Asthma

Blow for Nxera Pharma as Boehringer Ingelheim decides against licensing its schizophrenia compounds

Blow for Nxera Pharma as Boehringer Ingelheim decides against licensing its schizophrenia compounds

Soccer-Japan's Minamino ruptures ACL, World Cup campaign in doubt

Soccer-Japan's Minamino ruptures ACL, World Cup campaign in doubt

Frozen-food experiment brings 24-hour meal options to remote posts across Japan

Frozen-food experiment brings 24-hour meal options to remote posts across Japan

Decoding the 2025 Nobel Prize in Physiology or Medicine: The discovery of regulatory T cells, the “brakes” of immune responses

Decoding the 2025 Nobel Prize in Physiology or Medicine: The discovery of regulatory T cells, the “brakes” of immune responses

Former Mt. Gox CEO Mark Karpelès Reveals Details of 2014 Collapse and Japanese Detention

Former Mt. Gox CEO Mark Karpelès Reveals Details of 2014 Collapse and Japanese Detention

Samsung Bioepis Announces Approval of Ustekinumab Biosimilar in Japan

Show More

Video Stories

YouTube video thumbnail: China Urges Japan to Cease 'Provocative Actions' on Nuclear Weapons
Play
China Urges Japan to Cease 'Provocative Actions' on Nuclear Weapons
YouTube video thumbnail: Philippine City Residents Reject Islamic Militant Stigma After Alleged Link to Shooting
Play
Philippine City Residents Reject Islamic Militant Stigma After Alleged Link to Shooting
YouTube video thumbnail: Hopes new Darwin-to-China Flights Will Bring Down Domestic Airfares
Play
Hopes new Darwin-to-China Flights Will Bring Down Domestic Airfares
YouTube video thumbnail: Passenger bus Crash in Indonesia Kills at Least 16 People, Official Says
Play
Passenger bus Crash in Indonesia Kills at Least 16 People, Official Says

Video Title

Press Releases

Show More
Your brand’s story is being written — with or without you.
We’re the leading press release service for mid-sized businesses & organizations built for the AI era.
Learn more

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions